BRCA1 and neoplasm: Subsequent germline BRCA1/2 testing is then requested for patients with a positive tumour BRCA1/2 test result, thereby determining whether the pathogenic/likely pathogenic variant is constitutional (i.e., germline) or somatically acquired (i.e., tumour-only) [13].